AdvaMed Statement on President-elect Trump’s Intent to Nominate Dr. Martin Makary to Lead FDA

Washington, D.C., Nov. 19, 2024 - AdvaMed, the Medtech Association, released the following statement from President and CEO Scott Whitaker on President-elect Trump's announcement that he intends to nominate Dr. Martin Makary to Lead FDA:

"I know that Dr. Makary, as a renowned surgeon and professor at one of the world's top universities, understands the value of medical technologies in every health care setting. Access to the latest transformative medical technologies plays a key role in helping Americans to live longer and healthier lives. It is critical that FDA maintain the highest standards for safety and efficacy while ensuring the review process is efficient, transparent, and predictable to ensure every patient has access to the best medical technologies. We congratulate Dr. Makary on his nomination and look forward to his leadership at FDA."